Gastric cancer has the second highest mortality rate of all cancers worldwide. More attention is now being paid to the symptoms and risk factors involved. There is also increasing use of esophagastroduodenoscopy and random biopsies in symptomatic patients, especially as a screening mechanism in Japan. As a result, lesions are being diagnosed earlier.